Bredt David - Insider Non-Derivative Transactions at Rapport Therapeutics, Inc. (RAPP) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 15, 2025, Bredt David's relationship to Rapport Therapeutics, Inc. (RAPP) is Officer (Chief Scientific Officer), and currently has 393,438 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other RAPP insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Bredt David - Insider Non-Derivative Transactions of RAPP Common Stock

Bredt David - Insider Non-Derivative Transactions at RAPP

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 16, 2025	Sell -- (Common Stock)	796	30.68	392642
Dec 16, 2025	Sell -- (Common Stock)	7704	29.95	393438
Nov 18, 2025	Sell -- (Common Stock)	5344	25.39	401142
Nov 18, 2025	Sell -- (Common Stock)	3156	24.84	406486
Oct 16, 2025	Sell -- (Common Stock)	1082	26.16	409642
Oct 16, 2025	Sell -- (Common Stock)	7418	25.73	410724
Sep 16, 2025	Sell -- (Common Stock)	3402	24.66	418142
Sep 16, 2025	Sell -- (Common Stock)	5098	23.88	421544
Aug 16, 2025	Sell -- (Common Stock)	200	15.79	426642
Aug 16, 2025	Sell -- (Common Stock)	8300	14.98	426842
Jul 16, 2025	Sell -- (Common Stock)	8500	14	435142
Jun 17, 2025	Sell -- (Common Stock)	8500	11	443642
May 16, 2025	Sell -- (Common Stock)	8500	9.56	452142
Apr 16, 2025	Sell -- (Common Stock)	8500	9.57	460642
Mar 15, 2025	Sell -- (Common Stock)	8500	10.85	469142